We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-0.95%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$55.7B
AUM Growth
+$1.33B
Cap. Flow
+$2.27B
Cap. Flow %
4.08%
Top 10 Hldgs %
19.71%
Holding
3,688
New
269
Increased
1,855
Reduced
1,236
Closed
227

Sector Composition

Rank Sector Weight
1 Technology 10.05%
2 Financials 9.3%
3 Healthcare 7.74%
4 Industrials 6.94%
5 Communication Services 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIRT icon
2501
Virtu Financial
VIRT
$4.98B
$542K ﹤0.01%
+16,435
New +$425K
MPV
2502
Barings Participation Investors
MPV
$175M
$541K ﹤0.01%
36,797
-705
-2% -$10.2K
GLTR icon
2503
abrdn Physical Precious Metals Basket Shares ETF
GLTR
$2.72B
$540K ﹤0.01%
+8,398
New +$550K
HOMB icon
2504
Home BancShares
HOMB
$6.17B
$540K ﹤0.01%
23,673
-63
-0.3% -$1.51K
PWJ
2505
DELISTED
POWERSHARES DYNAMIC MID CAP GRTH PORTFOLIO
PWJ
$539K ﹤0.01%
+11,828
New +$539K
ANAB icon
2506
AnaptysBio
ANAB
$1.7B
$538K ﹤0.01%
5,165
+1,925
+59% +$217K
XHE icon
2507
State Street SPDR S&P Health Care Equipment ETF
XHE
$167M
$538K ﹤0.01%
7,721
+151
+2% +$10.3K
XLPS
2508
DELISTED
POWERSHARES S&P SMALLCAP CONSUMER STAPLES PORT
XLPS
$538K ﹤0.01%
7,695
+133
+2% +$9.3K
SFBS
2509
ServisFirst Bancshares
SFBS
$4.89B
$536K ﹤0.01%
13,133
+2,027
+18% +$85K
AVXS
2510
DELISTED
AveXis, Inc. Common Stock
AVXS
$536K ﹤0.01%
4,340
+234
+6% +$27.8K
HRC
2511
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$534K ﹤0.01%
6,141
+3,704
+152% +$317K
KYNB
2512
Kyntra Bio
KYNB
$28.9M
$533K ﹤0.01%
461
+27
+6% +$35.6K
PODD icon
2513
Insulet
PODD
$9.9B
$532K ﹤0.01%
+6,143
New +$477K
LTS
2514
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$532K ﹤0.01%
162,832
-1,994
-1% -$6.47K
NATH icon
2515
Nathan's Famous
NATH
$401M
$531K ﹤0.01%
7,185
-50
-0.7% -$3.49K
RH icon
2516
RH
RH
$3.4B
$531K ﹤0.01%
5,569
+612
+12% +$54.3K
VGR
2517
DELISTED
Vector Group Ltd.
VGR
$531K ﹤0.01%
40,469
-6,722
-14% -$89.9K
NTUS
2518
DELISTED
Natus Medical Inc
NTUS
$530K ﹤0.01%
+15,752
New +$499K
JTA
2519
DELISTED
Nuveen Tax-Advantaged Total Return Strategy Fund
JTA
$530K ﹤0.01%
40,751
+764
+2% +$10.5K
JPT
2520
DELISTED
Nuveen Preferred and Income Fund
JPT
$528K ﹤0.01%
21,550
+2,000
+10% +$48.6K
SR icon
2521
Spire
SR
$4.87B
$527K ﹤0.01%
7,290
-215
-3% -$14.7K
ZAYO
2522
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$527K ﹤0.01%
15,433
-1,664
-10% -$59.9K
HBK
2523
DELISTED
Hamilton Bancorp, Inc. Common Stock
HBK
$527K ﹤0.01%
+36,973
New +$555K
BIL icon
2524
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.7B
$526K ﹤0.01%
5,750
-83,841
-94% -$7.67M
VONV icon
2525
Vanguard Russell 1000 Value ETF
VONV
$21.9B
$526K ﹤0.01%
10,026
-860
-8% -$46.8K

Similar funds

Raymond James & Associates's Q1 2018 Portfolio in Review

As of Q1 2018, Raymond James & Associates held 3,688 positions worth $55.7B, up 2.4% from $54.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Raymond James & Associates deployed $2.27B of net new capital in Q1 2018, opening 269 new positions and adding to 1,855 existing holdings. Its largest new stake was Nutrien: 608,282 shares worth $28.7M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was AbbVie, an estimated $68.1M trimmed.

  • Raymond James & Associates's largest Q1 2018 buy was Nutrien: 608,282 shares worth $28.7M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2018, an estimated $211M increase.
  • Raymond James & Associates's biggest Q1 2018 reduction was AbbVie, cutting an estimated $68.1M.
  • Raymond James & Associates fully exited Regal Entertainment Group in Q1 2018, selling an estimated $48.4M.
  • Raymond James & Associates's ten largest holdings make up 20% of its $55.7B portfolio in Q1 2018.
  • Raymond James & Associates opened 269 new positions and closed 227 in Q1 2018.
  • Raymond James & Associates's portfolio value rose 2.4% quarter-over-quarter to $55.7B.

Based on Raymond James & Associates's 13F filing for Q1 2018, filed 14 May 2018.